{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:09:37Z","timestamp":1788473377677,"version":"build-2803163510"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100011015","name":"International Society of Travel Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>More people on immunosuppression live in or wish to travel to yellow fever virus (YFV)-endemic areas. Data on the safety and immunogenicity of yellow fever vaccination (YFVV) during immunosuppression are scarce. The aim of this study was to compare the safety and immunogenicity of a primary YFVV between travellers on methotrexate and controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a prospective multi-centre controlled observational study from 2015 to 2017 in six Swiss travel clinics. 15 adults (nine with rheumatic diseases, five with dermatologic conditions and one with a gastroenterological disease) on low-dose methotrexate (\u226420\u00a0mg\/week) requiring a primary YFVV and 15 age and sex-matched controls received a YFVV. Solicited\/unsolicited adverse reactions were recorded, YFV-RNA was measured in serum samples on Days 3, 7, 10, 14, 28 and neutralizing antibodies on Days 0, 7, 10, 14, 28.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients\u00b4 and controls\u2019 median ages were 53 and 52\u00a0years; 9 patients and 10 controls were female. 43% of patients and 33% of controls showed local side effects (P\u2009=\u20090.71); 86% of patients and 66% of controls reported systemic reactions (P\u2009=\u20090.39). YFV-RNA was detected in patients and controls on Day 3\u201310 post-vaccination and was never of clinical significance. Slightly more patients developed YFV-RNAaemia (Day 3: n\u2009=\u20095 vs n\u2009=\u20092, Day 7: n\u2009=\u20099 vs n\u2009=\u20097, Day 10: n\u2009=\u20093 vs n\u2009=\u20092, all P\u2009&amp;gt;\u20090.39). No serious reactions occurred. On Day 10, a minority of vaccinees was seroprotected (patients: n\u2009=\u20092, controls: n\u2009=\u20096). On Day 28, all vaccinees were seroprotected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>First-time YFVV was safe and immunogenic in travellers on low-dose methotrexate. Larger studies are needed to confirm these promising results.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jtm\/taaa126","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T19:12:10Z","timestamp":1595617930000},"source":"Crossref","is-referenced-by-count":18,"title":["Safety and immunogenicity of a primary yellow fever vaccination under low-dose methotrexate therapy\u2014a prospective multi-centre pilot study1"],"prefix":"10.1093","volume":"27","author":[{"given":"Silja","family":"B\u00fchler","sequence":"first","affiliation":[{"name":"Department of Public Health and Global Health\/Division of Infectious Diseases, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001 Zurich, Switzerland"},{"name":"Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, 20359 Hamburg, Germany"},{"name":"Division of Hygiene and Infectious Diseases, Institute of Hygiene and Environment, Marckmannstrasse 129a, 20539 Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika Katharina","family":"Jaeger","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland"},{"name":"Department of Clinical Epidemiology, Institute of Epidemiology and Social Medicine, University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1, 48149 M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Eperon","sequence":"additional","affiliation":[{"name":"Division of Tropical and Humanitarian Medicine, Department of Primary Care, Geneva University Hospitals (HUG), Rue Gabrielle-Perret-Gentil 6, 1205 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansjakob","family":"Furrer","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Bern University Hospital, University of Bern, Freiburgstrasse 15, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph A","family":"Fux","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Tellstrasse 25, 5001 Aarau, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Jansen","sequence":"additional","affiliation":[{"name":"Department of Arbovirology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, 20359 Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Neumayr","sequence":"additional","affiliation":[{"name":"Department of Medicine, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051 Basel, Switzerland"},{"name":"University of Basel, Socinstrasse 57, 4051 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Rochat","sequence":"additional","affiliation":[{"name":"Travel Clinic, Department of Ambulatory Care and Community Medicine, University Hospital Lausanne, Rue du Bugnon 21, 1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Schmid","sequence":"additional","affiliation":[{"name":"Department of Public Health and Global Health\/Division of Infectious Diseases, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Schmidt-Chanasit","sequence":"additional","affiliation":[{"name":"Department of Arbovirology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, 20359 Hamburg, Germany"},{"name":"Faculty of Mathematics, Informatics and Natural Sciences, University of Hamburg, Bundesstra\u00dfe 55, 20146 Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1733-7051","authenticated-orcid":false,"given":"Cornelia","family":"Staehelin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Bern University Hospital, University of Bern, Freiburgstrasse 15, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00ebtte W","family":"de Visser","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardus G","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Niedrig","sequence":"additional","affiliation":[{"name":"Robert Koch Institute (RKI), Seestra\u00dfe 10, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hatz","sequence":"additional","affiliation":[{"name":"Department of Public Health and Global Health\/Division of Infectious Diseases, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001 Zurich, Switzerland"},{"name":"Department of Medicine, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051 Basel, Switzerland"},{"name":"University of Basel, Socinstrasse 57, 4051 Basel, Switzerland"},{"name":"Department of Infectious Diseases and Hospital Hygiene, Cantonal Hospital St. Gallen, Rorschacherstrasse 95, 9007 St. Gallen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"2020092804151064900_ref1","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"2020092804151064900_ref2","article-title":"The Yellow Book. Chapter 5. Travelers with additional considerations. Immunocompromised travelers","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"2020092804151064900_ref3","article-title":"Immunization of immunocompromised persons: Canadian immunization guide","author":"Government of Canada","year":"2020"},{"key":"2020092804151064900_ref4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00103-019-02905-1","article-title":"Impfen bei Immundefizienz. Anwendungshinweise zu den von der St\u00e4ndigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entz\u00fcndlichen Erkrankungen und unter immunmodulatorischer Therapie","volume":"62","author":"Wagner","year":"2019","journal-title":"Bundesgesundheitsbl"},{"key":"2020092804151064900_ref5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/trstmh\/tru092","article-title":"The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases","volume":"108","author":"Johansson","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2020092804151064900_ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/taz040","article-title":"Severe yellow fever in Brazil: clinical characteristics and management","volume":"26","author":"Ho","year":"2019  11","journal-title":"J Travel Med"},{"key":"2020092804151064900_ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/taz015","article-title":"Yellow fever vaccination for immunocompromised travellers: unjustified vaccination hesitancy?","volume":"26","author":"De Jong","year":"2019  2","journal-title":"J Travel Med"},{"key":"2020092804151064900_ref8","first-page":"29","article-title":"Factors associated with severity of adverse events following yellow fever vaccination during the biggest outbreak of the disease recorded in Brazil, 2016-2017","volume":"23","author":"Lucena","year":"2020","journal-title":"Epidemiol Serv Saude"},{"key":"2020092804151064900_ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/tay026","article-title":"Adverse events in vaccinations for travelers - a 1-year prospective survey in a travel clinic in Germany","volume":"25","author":"Slesak","year":"2018","journal-title":"J Travel Med"},{"key":"2020092804151064900_ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/taw045","article-title":"Adverse event reports following yellow fever vaccination, 2007-13","volume":"23","author":"Lindsey","year":"2016  4","journal-title":"J Travel Med"},{"key":"2020092804151064900_ref11","first-page":"159","article-title":"Eiden\u00f6ssische Kommission f\u00fcr Impffragen (EKIF). Impfprinzipien und Empfehlungen f\u00fcr Personen mit autoimmunentz\u00fcndlichen rheumatischen Erkrankungen","author":"Bundesamt f\u00fcr Gesundheit (BAG)","year":"2014"},{"key":"2020092804151064900_ref12","article-title":"Chapter 3 Immunisation of immunocompromised persons [internet]","author":"Ireland's Health Services","year":"2020"},{"key":"2020092804151064900_ref13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s42358-019-0056-x","article-title":"Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases","volume":"59","author":"Pileggi","year":"2019","journal-title":"Adv Rheumatol"},{"key":"2020092804151064900_ref14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.vaccine.2017.01.048","article-title":"Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - a systematic review of randomized trials, observational studies and case reports","volume":"35","author":"Croce","year":"2017  1","journal-title":"Vaccine"},{"key":"2020092804151064900_ref15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1056\/NEJM196507222730404","article-title":"Circulating virus, interferon and antibody after vaccination with the 17-D strain ff yellow-fever virus","volume":"273","author":"Wheelock","year":"1965  22","journal-title":"N Engl J Med"},{"key":"2020092804151064900_ref16","doi-asserted-by":"crossref","first-page":"e27753","DOI":"10.1371\/journal.pone.0027753","article-title":"Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study","volume":"6","author":"Roukens","year":"2011","journal-title":"PLoS One"},{"key":"2020092804151064900_ref17","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.4049\/jimmunol.1500598","article-title":"Low thymic activity and dendritic cell numbers are associated with the immune response to primary viral infection in elderly humans","volume":"195","author":"Schulz","year":"2015  15","journal-title":"J Immunol"},{"key":"2020092804151064900_ref18","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/art.1780300501","article-title":"Immunologic studies of rheumatoid arthritis patients treated with methotrexate","volume":"30","author":"Olsen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"2020092804151064900_ref19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0889-857X(05)70327-6","article-title":"Infectious complications of immunosuppressive therapy in patients with rheumatic diseases","volume":"23","author":"Segal","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"2020092804151064900_ref20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/rheumatology\/kep101","article-title":"Methotrexate, rheumatoid arthritis and infection risk--what is the evidence?","volume":"48","author":"McLean-Tooke","year":"2009  1","journal-title":"Rheumatology"},{"key":"2020092804151064900_ref21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7326\/0003-4819-103-4-489","article-title":"Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study","volume":"103","author":"Andersen","year":"1985","journal-title":"Ann Intern Med"},{"key":"2020092804151064900_ref22","author":"World Health Organization","year":"2020"},{"key":"2020092804151064900_ref23","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/infdis\/jiz374","article-title":"Persistence of neutralizing antibody responses among yellow fever virus 17D vaccinees living in a nonendemic setting","volume":"221","author":"Kareko","year":"15  2020","journal-title":"J Infect Dis"},{"key":"2020092804151064900_ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/tay108","article-title":"Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers","volume":"25","author":"Lindsey","year":"2018  1","journal-title":"J Travel Med"},{"key":"2020092804151064900_ref25","author":"World Health Organization","year":"2019"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jtm\/advance-article-pdf\/doi\/10.1093\/jtm\/taaa126\/33549232\/taaa126.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jtm\/article-pdf\/27\/6\/taaa126\/33794526\/taaa126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jtm\/article-pdf\/27\/6\/taaa126\/33794526\/taaa126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T08:15:45Z","timestamp":1601280945000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/taaa126\/5878835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,7,30]]},"published-print":{"date-parts":[[2020,9,26]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/taaa126","relation":{},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"value":"1195-1982","type":"print"},{"value":"1708-8305","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,7,30]]},"article-number":"taaa126"}}